Alpha 2.0
Login Register
» Authors » Aaron Lucander

Aaron Lucander

Explore the profile of Aaron Lucander including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 22
Followers 0
Related Specialties
General Surgery
General Medicine
Pediatrics
Top 10 Co-Authors
Martin Tibudan
Karolina Golab
Lindsay Basto
Piotr Witkowski
Piotr J Bachul
John Fung
Ling-Jia Wang
Roi Anteby
Angelica Perez-Gutierrez
Laurencia Perea
Published In
Transplant Direct
Eur J Transl Clin Med
Pediatr Surg Int
Am J Transplant
Cell Transplant
Affiliations
Soon will be listed here.
Recent Articles
1.
Pain resolution and glucose control in pediatric patients with chronic pancreatitis after total pancreatectomy with islet auto-transplantation
Grybowski D, Bachul P, Pyda J, Kijek M, Fillman N, Perez-Gutierrez A, et al.
Pediatr Surg Int . 2021 Jul; 37(10):1383-1392. PMID: 34245339
Background: Chronic pancreatitis (CP) and acute recurrent pancreatitis (ARP) in pediatric patients are strongly associated with genetic mutations and lead to pan-parenchymal disease refractory to medical and endoscopic treatment. Our...
2.
Evaluating the Prognostic Value of Islet Autoantibody Monitoring in Islet Transplant Recipients with Long-Standing Type 1 Diabetes Mellitus
Anteby R, Lucander A, Bachul P, Pyda J, Grybowski D, Basto L, et al.
J Clin Med . 2021 Jul; 10(12). PMID: 34205321
(1) Background: The correlation between titers of islet autoantibodies (IAbs) and the loss of transplanted islets remains controversial. We sought to evaluate the prognostic utility of monitoring IAbs in diabetic...
3.
Post-Hoc Analysis of a Randomized, Double Blind, Prospective Study at the University of Chicago: Additional Standardizations of Trial Protocol are Needed to Evaluate the Effect of a CXCR1/2 Inhibitor in Islet Allotransplantation
Bachul P, Golab K, Basto L, Zangan S, Pyda J, Perez-Gutierrez A, et al.
Cell Transplant . 2021 Apr; 30:9636897211001774. PMID: 33908301
A recent randomized, multicenter trial did not show benefit of a CXCR1/2 receptor inhibitor (Reparixin) when analysis included marginal islet mass (>3,000 IEQ/kg) for allotransplantation and when immunosuppression regimens were...
4.
En bloc liver and pancreas transplantation after total pancreatectomy with autologous islet transplantation
S Generette G, Bachul P, Golab K, Basto L, Pyda J, Borek P, et al.
Eur J Transl Clin Med . 2021 Jan; 3(2):11-17. PMID: 33409500
We present a patient with intractable and debilitating pain secondary to chronic pancreatitis who was effectively treated with total pancreatectomy with islet autotransplantation (TPIAT). Islets engrafted into his liver significantly...
5.
Total pancreatectomy with islet autotransplantation in diabetic and pre-diabetic patients with intractable chronic pancreatitis
Bachul P, Grybowski D, Anteby R, Basto L, Perea L, Golab K, et al.
J Pancreatol . 2020 Oct; 3(2):86-92. PMID: 33005475
Total pancreatectomy with islet autotransplantation (TPIAT) is an effective treatment option for non-diabetic patients with intractable chronic pancreatitis. The outcome and potential benefits for pre-diabetic and diabetic patients are less...
6.
BETA-2 score is an early predictor of graft decline and loss of insulin independence after pancreatic islet allotransplantation
Bachul P, Golebiewska J, Basto L, Golab K, Anteby R, Wang L, et al.
Am J Transplant . 2019 Oct; 20(3):844-851. PMID: 31597009
This study aimed to evaluate whether the BETA-2 score is a reliable early predictor of graft decline and loss of insulin independence after islet allotransplantation. Islet transplant procedures were stratified...
7.
Very Late Recurrence of Hepatocellular Carcinoma After Orthotopic Liver Transplantation: Presentation and Management
Shaw B, Lucander A, Ravindra K
Transplant Direct . 2019 Oct; 5(9):e483. PMID: 31579811
No abstract available.